Myotonic dystrophy (DM) is a genetic disorder characterized by progressive muscle wasting and weakness, as well as various systemic manifestations. The Myotonic Dystrophy Market has been gaining attention in recent years due to advancements in research and development of treatment options, as well as increasing awareness of the disease among healthcare professionals and patients. This article...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian